Asthma

Longer-term therapy with omalizumab has been shown to improve asthma and reduce exacerbations. Investigators looked at the short-term effects of the medication.

10/05/2018

Asthma Snapshot

Reviewed by Albert Rizzo, MD

For allergic asthma content, visit the Disease State Hub

Asthma is a chronic inflammatory disease that can cause airflow obstruction. The airways can become inflamed and narrowed, making it difficult for air to flow when breathing out. About 1 in 13 people in the US has asthma, according to the CDC.

For more allergy content, visit the Resource Center

Primary Care, Pediatricians, Pulmonologists, Allergists, Respiratory Specialists, Internists

For more on the management of asthma, visit the Multidisciplinary Roundtable

Asthma attacks happen when the airways swell and narrow, making it harder to breathe. Attacks can come on fast or gradually and may be life-threatening. People with severe asthma tend to get asthma attacks more often.

For more expert perspective, visit the clinical insights page

Spirometry
FeNO Test
Trigger Tests
Allergy Tests

For polls and quizzes, visit the interactive features page

People with asthma in the United States, broken down by sex

For more pediatrics content, visit the Resource Center

Roughly the number of children under the age of 18 with asthma in the United States

October 2024

Current Issue

October 2024

Volume 64

Issue 9